ARCHIVES

FDA Didn’t Tell Advisors About Data Linking Obesity Drug With Precancerous Lesions.

This article is from The Cancer Letter archive.

Vol. 32 No. 21 | June 2, 2006

Download PDF Visit The Full Archive

Related Articles

JCO Retracts Key Duke Genomics Paper; Duke Shuts Down Three Phase II Trials

November 19, 2010

GYN Group: Open Surgery Would Cost More Lives Than Morcellation

July 25, 2014

O’Neill Account, Kennedy Hearing, Create Climate On Capitol Hill for Increasing Cancer Funding

May 3, 1991

Judge Rules First Amendment Protects Distribution Of Off-Label Use Information

August 14, 1998

In Brief: Greenwald Reorganizing DCPC, Elevates Surveillance to Program, Moves Branches

February 3, 1989

Ad Council, ACS Begin Ad Campaign To Promote Colon Cancer Screening.

February 1, 2002